Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Nippon Shinyaku Selects and Deploys the Symyx Notebook by Accelrys

Published: Monday, November 28, 2011
Last Updated: Monday, November 28, 2011
Bookmark and Share
Accelrys Electronic Laboratory Notebook drives R&D efficiency and eases regulatory burdens

Accelrys, Inc, the software and services company, has announced that Nippon Shinyaku Co. selected the Symyx Notebook by Accelrys Electronic Laboratory Notebook (ELN) after evaluating various vendors and successfully launched the solution in August.

"In 2010, Nippon began evaluating ELN solutions for two labs in two locations. After evaluating several vendors' offerings, we found that the Symyx Notebook by Accelrys offered the best solution for boosting research efficiency and meeting the challenges imposed by government regulations and legislation," said Dr. Masato Matsuoka, general manager of Nippon Shinyaku Co. "Our initial ELN deployment has been very successful in meeting these goals, and we look forward to collaborating with Accelrys on a broader roll out."

Nippon had two objectives in moving to an ELN. First, they wanted to boost research efficiency and accelerate patent applications by moving from paper to more flexible electronic templates. Second, they wanted the ability to respond quickly to legislative and regulatory requirements to track test reagents and products back to the beginning of the product planning cycle.

Nippon began production in the Exploratory Synthetic Division leveraging The Symyx Notebook by Accelrys in August of this year; it plans to expand the ELN system to other areas of the company in the near future. Accelrys Professional Services, in partnership with CTC Laboratory Systems Corporation (CTCLS), also provided implementation support, analyzing the existing business operations of its R&D departments and undertaking a complete overhaul of its workflow processes, helping eliminate wastefulness and inefficiencies in its experiment procedures. The Accelrys Professional Services team has extensive ELN deployment experience and works with its partner CTCLS to support Japanese customers in realizing their ELN project goals. As a result of this project, Nippon succeeded in their Business Process Reengineering (BPR) project and expects to improve the overall efficiency of its R&D activities.

"ELNs are quickly becoming the standard in global R&D labs, from pharmaceutical development to academic research," said Accelrys President and Chief Executive Officer Max Carnecchia. "Accelrys, with our commitment to science and successful software deployments in various verticals, is uniquely positioned to partner with customers on an ELN implementation that will return immediate, measurable results. I look forward to further collaboration with Nippon Shinyaku and seeing how the progress they make will impact the next generation of pharmaceuticals."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Accelrys Announces 2012 US Tech Summit for IT Professionals
Fourth US Tech Summit for Accelrys customers will take place October 16-17 in New Jersey.
Sunday, October 21, 2012
Aquavit Pharmaceuticals Forms Alliance Partnership with Accelrys
Aquavit to utilize the Accelrys Enterprise Platform to develop advanced medical software for cutting-edge personalized medicine.
Sunday, October 14, 2012
Accelrys Announces Software Licensing Agreement with Gulf Coast Consortia
Tailored academic license defines new informatics standard for multi-center collaborative research and Cloud-based data sharing
Saturday, June 02, 2012
Accelrys Acquires VelQuest Corporation for $35 Million in Cash
Extends reach downstream in the lab-to-market value chain with addition of industry-leading lab execution and data capture software
Monday, March 19, 2012
Accelrys Acquires VelQuest
Accelrys adds paperless lab execution systems to portfolio with acquisition of VelQuest Corporation.
Friday, January 06, 2012
Leading Scientists to Present Computational and Informatics Solutions at Accelrys Science Forum Series
Seminars will feature top researchers discussing in silico solutions for pharmaceutical, biotech and chemicals R & D organizations.
Wednesday, October 10, 2007
Accelrys Launches NanoBiology Initiative
Initiative will bring together industry, government and academic experts to drive nanobiology innovation.
Wednesday, November 16, 2005
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
New Medication Shows Promise Against Liver Fibrosis in Animal Studies
Liver fibrosis is a gradual scarring of the liver that puts people at risk for progressive liver disease and liver failure.
Raw Eggs Deemed Safe to Eat
A report published today by the Advisory Committee on the Microbiological Safety of Food (ACMSF) into egg safety has shown a major reduction in the risk from salmonella in UK eggs.
Monitoring TTX Toxin in Shellfish
In a number of small studies, mussels and oysters from the eastern and northern part of the Oosterschelde in Holland were found to contain tetrodotoxin (TTX).
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Detecting Alzheimer's with Smell Test
Odour identification test may offer low-cost alternative for predicting cognitive decline and detecting early-stage Alzheimer’s disease.
Antibody Drug Shows Promise in HIV Treatment
Researchers are a step closer to an alternative HIV treatment that has the potential for lasting effects and less frequent dosing.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!